← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Manchester
Manchester
$22,238,620
Total funding
10
Grants
Funding over time
peak $2.1M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$20,832,136 · 8
FDA$1,406,484 · 2
By mechanism
U01$17,607,678 · 4
R01$4,228,480 · 4
R03$213,462 · 1
R21$189,000 · 1
Investigators at University Of Manchester
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up$1,691,777
U01 · FY2019 · DE
TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up$1,566,560
U01 · FY2015 · DE
TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up$1,562,574
U01 · FY2018 · DE
Timing of Primary Surgery for Cleft Palate$1,518,859
U01 · FY2008 · DE
GENOME SEQUENCING OF ASPERGILLUS FUMIGATUS$1,500,037
U01 · FY2001 · AI
GENOME SEQUENCING OF ASPERGILLUS FUMIGATUS$1,500,000
U01 · FY2000 · AI
TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up$1,478,290
U01 · FY2017 · DE
TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up$1,315,176
U01 · FY2016 · DE
Timing of Primary Surgery for Cleft Palate$1,216,305
U01 · FY2010 · DE
Timing of Primary Surgery for Cleft Palate$1,076,844
U01 · FY2009 · DE
Timing of Primary Surgery for Cleft Palate$937,760
U01 · FY2011 · DE
Timing of Primary Surgery for Cleft Palate$837,012
U01 · FY2012 · DE
Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy$301,204
R01 · FY2008 · DK
Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy$301,126
R01 · FY2010 · DK
Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics$299,568
U01 · FY2022 · FD
Integration of Drug Release and Permeability with Systems Data Relevant to PBPK Model of Nose-to-Brain Axis and Verification Using Clinical Data$297,306
U01 · FY2022 · FD
Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy$296,815
R01 · FY2011 · DK
Corneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathy$296,632
R01 · FY2009 · DK
Quantitative Expression and Inter-Individual Variability of Skin Proteins Involved in Drug and Excipient Metabolism and Transporters Using Targeted and Label Free LC MS/MS Proteomics$296,354
U01 · FY2021 · FD
Emotional Stress and Wound Healing in Diabetes$283,786
R01 · FY2007 · DK